World's Best Scientists 2026 revealed!
Kazuaki Shimamoto

Kazuaki Shimamoto

D-Index & Metrics

Medicine

D-Index
87
Citations
29427
World Ranking
13591
National Ranking
404

Kazuaki Shimamoto publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kazuaki Shimamoto sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 790 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kazuaki Shimamoto D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kazuaki Shimamoto sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kazuaki Shimamoto is affiliated with Sapporo Medical University in Japan and has contributed extensively to research in medicine, with a focus on epidemiology, cardiology, endocrinology, molecular biology, and public health. Their research encompasses several aspects of metabolic disorders, cardiovascular health, and liver disease diagnostics.

Their recent publications include work on diverse topics such as obesity and its biochemical impacts, cardiovascular disease risk classification, fatty acid-binding proteins, and COVID-19 related lung injury. Notable papers include:

  • Differential regulation of hypoxanthine and xanthine by obesity in a general population, 2020, Journal of Diabetes Investigation
  • Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19, 2020, Hypertension Research
  • Risk Classification for Metabolic Syndrome and the Incidence of Cardiovascular Disease in Japan With Low Prevalence of Obesity: A Pooled Analysis of 10 Prospective Cohort Studies, 2021, Journal of the American Heart Association
  • Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study, 2021, Scientific Reports
  • Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals, 2021, Journal of Diabetes Investigation

Shimamoto collaborates frequently with several coauthors, including Masato Furuhashi, Masayuki Koyama, Yukimura Higashiura, Hirofumi Ohnishi, and Marenao Tanaka, reflecting ongoing partnerships in multiple research projects.

Research output is published in venues such as:

  • Hypertension Research
  • Journal of Diabetes Investigation
  • Journal of the American Heart Association
  • Scientific Reports
  • The American Journal of Cardiology

Their main fields of study highlight medicine in general, with specific subfields concentrating on epidemiology, cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, molecular biology, and public health environmental and occupational health.

Key topics within Shimamoto's research include:

  • Liver Disease Diagnosis and Treatment
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Gout, Hyperuricemia, Uric Acid
  • Alcohol Consumption and Health Effects
  • COVID-19 Clinical Research Studies
  • Heart Rate Variability and Autonomic Control
  • Peroxisome Proliferator-Activated Receptors

Best Publications

  • The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

    Toshio Ogihara;Kenjiro Kikuchi;Hiroaki Matsuoka;Toshiro Fujita

  • The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014)

    Kazuaki Shimamoto;Katsuyuki Ando;Toshiro Fujita;Naoyuki Hasebe

  • Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1

    Masaya Tanno;Jun Sakamoto;Tetsuji Miura;Kazuaki Shimamoto

  • Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension

    Masato Furuhashi;Nobuyuki Ura;Katsuhiro Higashiura;Hideyuki Murakami

  • Erratum: The Japanese Society of hypertension guidelines for the management of hypertension (Hypertension Research (2009) 32 (11-23) DOI: 10.1038/hr.2008.2)

    Toshio Ogihara;Kenjiro Kikuchi;Hiroaki Matsuoka;Toshiro Fujita

  • Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.

    Masato Furuhashi;Shigeyuki Saitoh;Kazuaki Shimamoto;Tetsuji Miura

  • Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study

    Toshio Ogihara;Takao Saruta;Hiromi Rakugi;Hiroaki Matsuoka

  • Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure.

    Masaya Tanno;Atsushi Kuno;Toshiyuki Yano;Tetsuji Miura

  • Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance

    Ryuzo Kawamori;Naoko Tajima;Yasuhiko Iwamoto;Atsunori Kashiwagi

  • Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese

    Tamio Teramoto;Jun Sasaki;Hirotsugu Ueshima;Genshi Egusa

  • Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

    Masunori Matsuzaki;Toru Kita;Hiroshi Mabuchi;Yuji Matsuzawa

  • Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study

    Kazuaki Shimamoto;Naoyuki Hasebe;Sadayoshi Ito;Kazuomi Kario

  • High plasma immunoreactive leptin level in essential hypertension.

    Jun Agata;Atsushi Masuda;Mikio Takada;Katsuhiro Higashiura

  • The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

    Toshio Ogihara;Kenjiro Kikuchi;Toshiro Fujita;Jitsuo Higaki

  • Modulation of the mitochondrial permeability transition pore complex in GSK-3β-mediated myocardial protection

    Masahiro Nishihara;Tetsuji Miura;Takayuki Miki;Masaya Tanno

  • Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker

    Masato Furuhashi;Norihito Moniwa;Tomohiro Mita;Takahiro Fuseya

  • Diagnostic Criteria for Dyslipidemia — Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese

    Tamio Teramoto;Jun Sasaki;Hirotsugu Ueshima;Genshi Egusa

  • Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study

    Takeshi Isobe;Shigeyuki Saitoh;Satoru Takagi;Hiroshi Takeuchi

  • Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts

    Tomoaki Nakata;Kenjiroh Miyamoto;Atsushi Doi;Hisataka Sasao

  • Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients

    Toshio Ogihara;Takao Saruta;Hiromi Rakugi;Kazuaki Shimamoto

Frequent Co-Authors

Toshio Ogihara
Toshio Ogihara Osaka University
Hiromi Rakugi
Hiromi Rakugi Osaka University
Masunori Matsuzaki
Masunori Matsuzaki Yamaguchi University
Sadayoshi Ito
Sadayoshi Ito Tohoku University
Hirotsugu Ueshima
Hirotsugu Ueshima Shiga University of Medical Science
Yoshiyuki Horio
Yoshiyuki Horio Sapporo Medical University
Takao Saruta
Takao Saruta Keio University
Toru Kita
Toru Kita Kyoto University
Tomohiro Katsuya
Tomohiro Katsuya Osaka University
Kazuyuki Shimada
Kazuyuki Shimada Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in healthcare careers beyond becoming a physician, a range of online degrees and fast-track options are available. For those looking to enter the nursing field quickly, an accelerated lpn program can help you become a Licensed Practical Nurse in less time, opening the door to direct patient care roles.

Nurses who already hold a master’s degree and want to specialize further often look at advanced practice roles. The shortest post master's pmhnp online programs allow registered nurses to become Psychiatric Mental Health Nurse Practitioners through flexible and efficient online pathways.

For those more interested in the administrative side of healthcare, earning a bachelors in health administration provides foundational knowledge for management roles in hospitals and clinics. Graduates can advance further by pursuing the cheapest online master degree in healthcare administration, equipping them for leadership and executive opportunities.

Exploring these related online degrees can help you find the right pathway in healthcare, whether you’re passionate about clinical care or healthcare management.

Best Scientists Citing Kazuaki Shimamoto

Trending Scientists

Recently Published Articles